INMB - Latest News

INmune Bio, Inc. (INMB), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $38.8M. Beta to the broader market is 1.05.

The article list below shows the most recent INMB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent INMB Headlines

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

globenewswire.com - May 15, 2026

Boca Raton, FL, May 15, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing therapies that tar

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

globenewswire.com - May 14, 2026

BOCA RATON, FL, May 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immun

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

globenewswire.com - May 13, 2026

Alliance launches with 26 founding companies to develop a national strategy for U. S.

INmune Bio Inc. (INMB) Q1 2026 Earnings Call Prepared Remarks Transcript

seekingalpha.com - May 8, 2026

INmune Bio Inc.

INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

globenewswire.com - May 7, 2026

BOCA RATON, Fla. , May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc.

How News Affects INMB Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track INMB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked INMB news questions

What is the latest INMB news headline?
The most recent INMB headline (May 15, 2026) is "INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the INMB news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What INMB news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual INMB options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.